Viatris

Company

Also known as: Viatris

Company Profile

Viatris is a global healthcare company formed through the combination of Mylan and Upjohn. It provides branded, generic, and complex medicines across many markets.

Website: https://www.viatris.com
Headquarters: Canonsburg, Pennsylvania, USA
Founded: 2020
Stock Ticker: NASDAQ:VTRS

Related News

EMA Approves Shield Therapeutics' FeRACCRU for Adolescents Following FDA Pediatric Authorization

Mar 31, 2026

The European Medicines Agency has approved Shield Therapeutics' FeRACCRU® for adolescents aged 12 and older, following FDA approval of ACCRUFeR® for children 10+. The expansion was supported by Phase 3 pediatric trial data showing efficacy and safety in children as young as 1 month.

FDA Accepts Viatris Presbyopia Treatment Application, Approves Rival Eye Drop Therapy

Feb 25, 2026

The FDA accepted Viatris' application for phentolamine ophthalmic solution 0.75% to treat presbyopia, with a decision expected October 2026. Separately, the agency approved Yuvezzi, a once-daily combination eye drop for age-related near vision loss.